508 related articles for article (PubMed ID: 3512234)
21. Evaluation of the in-vitro antibacterial activity of Sch 34343.
Adam C; Naples L; Weiss W; Sabatelli F; Hare R; Loebenberg D; Miller GH
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():39-56. PubMed ID: 3875604
[TBL] [Abstract][Full Text] [Related]
22. Empiric antibiotic use--aztreonam as a model.
Levin S
Am J Med; 1990 Mar; 88(3C):21S-23S; discussion 38S-42S. PubMed ID: 2316555
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion.
Burgess DS; Summers KK; Hardin TC
Clin Ther; 1999 Nov; 21(11):1882-9. PubMed ID: 10890260
[TBL] [Abstract][Full Text] [Related]
24. Summary of worldwide clinical trials of aztreonam in patients with urinary tract infections.
Swabb EA; Jenkins SA; Muir JG
Rev Infect Dis; 1985; 7 Suppl 4():S772-7. PubMed ID: 3909336
[TBL] [Abstract][Full Text] [Related]
25. Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Barradell LB; Bryson HM
Drugs; 1994 Mar; 47(3):471-505. PubMed ID: 7514976
[TBL] [Abstract][Full Text] [Related]
26. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
Scully BE; Neu HC
Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
[TBL] [Abstract][Full Text] [Related]
27. Aztreonam activity, pharmacology, and clinical uses.
Neu HC
Am J Med; 1990 Mar; 88(3C):2S-6S; discussion 38S-42S. PubMed ID: 2180293
[TBL] [Abstract][Full Text] [Related]
28. Ceftizoxime: a beta-lactamase-stable, broad-spectrum cephalosporin. Pharmacokinetics, adverse effects and clinical use.
Neu HC
Pharmacotherapy; 1984; 4(2):47-60. PubMed ID: 6326062
[TBL] [Abstract][Full Text] [Related]
29. A comparison of monobactam antibiotics in surgical infections.
DiPiro JT; Bowden TA
Am J Surg; 1989 Jun; 157(6):607-14. PubMed ID: 2658643
[TBL] [Abstract][Full Text] [Related]
30. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
Klietmann W; Focht J; Nösner K
Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
[TBL] [Abstract][Full Text] [Related]
31. Clinical experience with aztreonam in Germany and Austria.
Stille W; Gillissen J
Rev Infect Dis; 1985; 7 Suppl 4():S825-30. PubMed ID: 3909342
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of low dose aztreonam in the treatment of moderate to severe gram-negative bacterial infections.
Clergeot A; Steru D; Rosset MA; Carbon C
J Antimicrob Chemother; 1989 May; 23(5):753-8. PubMed ID: 2759924
[TBL] [Abstract][Full Text] [Related]
33. The use of aztreonam in serious gram-negative infections.
Smith G; Bunney RG; Farrell ID; Wood MJ
J Antimicrob Chemother; 1988 Feb; 21(2):233-41. PubMed ID: 3283094
[TBL] [Abstract][Full Text] [Related]
34. [Aztreonam treatment of severe infections caused by gram-negative aerobic bacilli].
Peter JD; Jehl F; Froehly S; Dupeyron JP; Monteil H; Rosset MA
Pathol Biol (Paris); 1988 May; 36(5):525-30. PubMed ID: 3043352
[TBL] [Abstract][Full Text] [Related]
35. A review of the pharmacokinetics and pharmacodynamics of aztreonam.
Ramsey C; MacGowan AP
J Antimicrob Chemother; 2016 Oct; 71(10):2704-12. PubMed ID: 27334663
[TBL] [Abstract][Full Text] [Related]
36. The use of aztreonam in pediatric patients: a review.
Bosso JA; Black PG
Pharmacotherapy; 1991; 11(1):20-5. PubMed ID: 1902290
[TBL] [Abstract][Full Text] [Related]
37. Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections.
Birolini D; Moraes MF; de Souza OS
Chemotherapy; 1989; 35 Suppl 1():49-57. PubMed ID: 2659290
[TBL] [Abstract][Full Text] [Related]
38. The role of aztreonam in treatment of complicated urinary tract infections in children.
Kline MW
Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S113-6; discussion S128-32. PubMed ID: 2682509
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of azthreonam, a monobactam antibiotic.
Jacobus NV; Ferreira MC; Barza M
Antimicrob Agents Chemother; 1982 Nov; 22(5):832-8. PubMed ID: 6891198
[TBL] [Abstract][Full Text] [Related]
40. The monobactams.
Brewer NS; Hellinger WC
Mayo Clin Proc; 1991 Nov; 66(11):1152-7. PubMed ID: 1943248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]